Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$536.87 USD

536.87
1,636,065

+5.01 (0.94%)

Updated Jul 10, 2024 04:00 PM ET

After-Market: $536.96 +0.09 (0.02%) 5:28 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (152 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

The Zacks Analyst Blog Highlights Merck, Thermo Fisher Scientific, American Express, Valero Energy and Weyerhaeuser

by Zacks Equity Research

Merck, Thermo Fisher Scientific, American Express, Valero Energy and Weyerhaeuser are part of the Zacks top Analyst Blog.

Mark Vickery headshot

Top Stock Reports for Merck, Thermo Fisher Scientific & American Express

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Thermo Fisher Scientific Inc. (TMO) and American Express Company (AXP).

Select Medical (SEM) Enters JV to Boost New Jersey Healthcare

by Zacks Equity Research

Select Medical (SEM) collaborates with AtlantiCare to open an inpatient rehabilitation hospital and jointly manage the operations of SEM's outpatient centers across New Jersey.

Thermo Fisher (TMO) Rides on Strong End Markets, New Launches

by Zacks Equity Research

Thermo Fisher's (TMO) newly-launched Gibco CTS DynaCellect Magnetic Separation System is helping customers advance their cell and gene therapy programs.

Encompass Health's (EHC) Shares Up 3% on Q4 Earnings Beat

by Zacks Equity Research

Encompass Health's (EHC) fourth-quarter results reflect growing patient volumes and reimbursement rates. Management expects 2023 adjusted EPS within $2.87-$3.16, higher than $2.85 in 2022.

Catalent (CTLT) Surges on Rumors of Acquisition by Danaher

by Zacks Equity Research

Catalent (CTLT) shares gain significantly, following a Bloomberg report about a potential acquisition of the CDMO company by Danaher, a life sciences company.

Cigna (CI) Q4 Earnings Top on U.S. Commercial Unit, Dividend Up

by Zacks Equity Research

Cigna's (CI) fourth-quarter results reflect the strong contribution from the Evernorth segment. Management sanctions a 10% increase in the quarterly dividend.

Thermo Fisher (TMO) Upgraded to Buy: What Does It Mean for the Stock?

by Zacks Equity Research

Thermo Fisher (TMO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Company News for Feb 2, 2023

by Zacks Equity Research

Companies in The News Are: ALGN, TMO, ATKR, WRK.

Thermo Fisher (TMO) Q4 Earnings Beat Estimates, Margins Down

by Zacks Equity Research

Robust year-over-year growth in the Analytical Instruments and the Laboratory Products and Biopharma Services segments boost Thermo Fisher's (TMO) Q4 revenues.

Thermo Fisher (TMO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Thermo Fisher Scientific (TMO) Surpasses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Thermo Fisher (TMO) delivered earnings and revenue surprises of 4.05% and 10.55%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Medical Device Stocks' Earnings on Feb 1: BSX, TMO & More

by Urmimala Biswas

Medical device companies' results are likely to reflect a sequential decline. Let's see how BSX, TMO, HOLX and ALGN fare this time.

Thermo Fisher Scientific (TMO) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Thermo Fisher Scientific (TMO) closed at $575.32 in the latest trading session, marking a -0.93% move from the prior day.

Earnings Preview: Thermo Fisher Scientific (TMO) Q4 Earnings Expected to Decline

by Zacks Equity Research

Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's in Store for Thermo Fisher (TMO) in Q4 Earnings?

by Zacks Equity Research

The industrywide trend of record-level inflation, supply issues and staffing shortages are expected to have deterred growth in several areas of Thermo Fisher's (TMO) business in Q4.

Abhinab Dasgupta headshot

Beat the Market Like Zacks: Boeing, Starbucks, Syndax Pharma in Focus

by Abhinab Dasgupta

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Thermo Fisher Scientific (TMO) closed the most recent trading day at $583.86, moving +0.66% from the previous trading session.

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

by Zacks Equity Research

Sector ETF report for IHI

Thermo Fisher Scientific (TMO) Stock Moves 0.4%: What You Should Know

by Zacks Equity Research

Thermo Fisher Scientific (TMO) closed the most recent trading day at $583.84, moving +0.4% from the previous trading session.

Thermo Fisher Scientific (TMO) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Thermo Fisher Scientific (TMO) closed at $581.54 in the latest trading session, marking a -0.18% move from the prior day.

Strength Seen in Inari Medical, Inc. (NARI): Can Its 5.6% Jump Turn into More Strength?

by Zacks Equity Research

Inari Medical, Inc. (NARI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Starbucks, Moderna, Canadian Pacific Railway and Micron Technology

by Zacks Equity Research

Thermo Fisher Scientific, Starbucks, Moderna, Canadian Pacific Railway and Micron Technology are included in this Analyst Blog.

Sheraz Mian headshot

Top Stock Reports for Thermo Fisher Scientific, Starbucks & Moderna

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc. (TMO), Starbucks Corporation (SBUX) and Moderna, Inc. (MRNA).

Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Thermo Fisher Scientific (TMO) closed at $553.18 in the latest trading session, marking a +0.45% move from the prior day.